These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32653591)

  • 1. Type 2 diabetes mellitus decreases systemic exposure of clopidogrel active metabolite through upregulation of P-glycoprotein in rats.
    Yao H; Gu J; Shan Y; Wang Y; Chen X; Sun D; Guo Y
    Biochem Pharmacol; 2020 Oct; 180():114142. PubMed ID: 32653591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Platelet Response to Clopidogrel in Zucker Diabetic Fatty Rats due to Impaired Clopidogrel Inactivation by Carboxylesterase 1 and Increased Exposure to Active Metabolite.
    Yao H; Bai R; Ren T; Wang Y; Gu J; Guo Y
    Drug Metab Dispos; 2019 Aug; 47(8):794-801. PubMed ID: 31092394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotics-induced disruption of gut microbiota increases systemic exposure of clopidogrel active metabolite in type 2 diabetic rats.
    Chen X; Liu Y; Yao H; Song W; Song Y; Gu J; Guo Y
    Drug Metab Dispos; 2022 Jul; ():. PubMed ID: 35858690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Atorvastatin Pharmacokinetics in High-Fat Diet and Low-Dose Streptozotocin-Induced Diabetic Rats Using a Semiphysiologically Based Pharmacokinetic Model Involving Both Enzymes and Transporters.
    Wang Z; Yang H; Xu J; Zhao K; Chen Y; Liang L; Li P; Chen N; Geng D; Zhang X; Liu X; Liu L
    Drug Metab Dispos; 2019 Oct; 47(10):1066-1079. PubMed ID: 31399507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased plasma exposure of clopidogrel active metabolite in rats after long-term treatment with clopidogrel.
    Wang Y; Liu Y; Yao H; Chen X; Sun Y; Guo Y
    Biopharm Drug Dispos; 2023 Apr; 44(2):129-136. PubMed ID: 36905582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease.
    Angiolillo DJ; Jakubowski JA; Ferreiro JL; Tello-Montoliu A; Rollini F; Franchi F; Ueno M; Darlington A; Desai B; Moser BA; Sugidachi A; Guzman LA; Bass TA
    J Am Coll Cardiol; 2014 Sep; 64(10):1005-14. PubMed ID: 25190236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-glycoprotein deficiency enhances metabolic activation of and platelet response to clopidogrel through marked up-regulation of Cyp3a11 in mice: Direct evidence for the interplay between P-glycoprotein and Cyp3a.
    Ji JZ; Li YF; Jiang LP; Tai T; Ge PX; Mi QY; Zhu T; Xie HG
    Biochem Pharmacol; 2021 Jan; 183():114313. PubMed ID: 33137324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologically-Based Pharmacokinetic-Pharmacodynamics Model Characterizing CYP2C19 Polymorphisms to Predict Clopidogrel Pharmacokinetics and Its Anti-Platelet Aggregation Effect Following Oral Administration to Coronary Artery Disease Patients With or Without Diabetes.
    Xu RJ; Kong WM; An XF; Zou JJ; Liu L; Liu XD
    Front Pharmacol; 2020; 11():593982. PubMed ID: 33519456
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
    Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
    Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of arctigenin in normal and type 2 diabetic rats after oral and intravenous administration.
    Zeng XY; Dong S; He NN; Jiang CJ; Dai Y; Xia YF
    Fitoterapia; 2015 Sep; 105():119-26. PubMed ID: 26102179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the potential drug-drug interaction between carvedilol and clopidogrel mediated through intestinal P-glycoprotein.
    Incecayir T; Ilbasmis-Tamer S; Tirnaksiz F; Degim T
    Pharmazie; 2016 Aug; 71(8):472-477. PubMed ID: 29442035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma exposures of five protoberberine alkaloids from Coptidis Rhizoma in streptozotocin-induced diabetic rats: is P-GP involved?
    Yu S; Yu Y; Liu L; Wang X; Lu S; Liang Y; Liu X; Xie L; Wang G
    Planta Med; 2010 Jun; 76(9):876-81. PubMed ID: 20108175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined contributions of impaired hepatic CYP2C11 and intestinal breast cancer resistance protein activities and expression to increased oral glibenclamide exposure in rats with streptozotocin-induced diabetes mellitus.
    Liu H; Liu L; Li J; Mei D; Duan R; Hu N; Guo H; Zhong Z; Liu X
    Drug Metab Dispos; 2012 Jun; 40(6):1104-12. PubMed ID: 22393122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic understanding of the effect of Dengzhan Shengmai capsule on the pharmacokinetics of clopidogrel in rats.
    Chen X; Zhao Z; Chen Y; Gou X; Zhou Z; Zhong G; Cai Y; Huang M; Jin J
    J Ethnopharmacol; 2016 Nov; 192():362-369. PubMed ID: 27459888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes.
    Xu D; Li F; Zhang M; Zhang J; Liu C; Hu MY; Zhong ZY; Jia LL; Wang DW; Wu J; Liu L; Liu XD
    Acta Pharmacol Sin; 2014 Sep; 35(9):1215-25. PubMed ID: 25152023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of P-glycoprotein on clopidogrel absorption.
    Taubert D; von Beckerath N; Grimberg G; Lazar A; Jung N; Goeser T; Kastrati A; Schömig A; Schömig E
    Clin Pharmacol Ther; 2006 Nov; 80(5):486-501. PubMed ID: 17112805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Stay-Green Wheat, a Novel Variety of Wheat in China, on Glucose and Lipid Metabolism in High-Fat Diet Induced Type 2 Diabetic Rats.
    Ji J; Zhang C; Luo X; Wang L; Zhang R; Wang Z; Fan D; Yang H; Deng J
    Nutrients; 2015 Jun; 7(7):5143-55. PubMed ID: 26132991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite effect of diabetes mellitus induced by streptozotocin on oral and intravenous pharmacokinetics of verapamil in rats.
    Hu N; Xie S; Liu L; Wang X; Pan X; Chen G; Zhang L; Liu H; Liu X; Liu X; Xie L; Wang G
    Drug Metab Dispos; 2011 Mar; 39(3):419-25. PubMed ID: 21135265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Darapladib inhibits atherosclerosis development in type 2 diabetes mellitus Sprague-Dawley rat model.
    Wihastuti TA; Heriansyah T; Hanifa H; Andarini S; Sholichah Z; Sulfia YH; Adam AA; Refialdinata J; Lutfiana NC
    Endocr Regul; 2018 Apr; 52(2):69-75. PubMed ID: 29715185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What kinds of substrates show P-glycoprotein-dependent intestinal absorption? Comparison of verapamil with vinblastine.
    Ogihara T; Kamiya M; Ozawa M; Fujita T; Yamamoto A; Yamashita S; Ohnishi S; Isomura Y
    Drug Metab Pharmacokinet; 2006 Jun; 21(3):238-44. PubMed ID: 16858128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.